State-of-the-art Manufacturing Facility Opens in China

State-of-the-art manufacturing facility in Hebei, China

​Bimeda is pleased to announce that its state-of-the-art manufacturing facility in Hebei, China, has just received its Chinese GMP accreditation. This sterile injectable manufacturing facility is designed and built to China's highest regulatory standards.

The facility boasts a sterile injectable product filling line in a grade B+A environment, and the capacity to fill vial sizes between 10ml and 100ml.

The site also offers a full capability laboratory, as well as an on-site validation team, an on-site quality team and both raw material and finished goods storage.

Bimeda Acquires AquaTactics Fish Health
Bimeda Announces Acquisition of Grupo Unipharm Vet...